Patents by Inventor Mark B. Nolt

Mark B. Nolt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazolopyridinone PDE10 inhibitors
    Patent number: 9266881
    Abstract: The present invention is directed to triazolopyridinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: February 23, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: James C. Barrow, Christopher D. Cox, Mark B. Nolt, William D. Shipe
  • TRIAZOLOPYRIDINONE PDE10 INHIBITORS
    Publication number: 20140343053
    Abstract: The present invention is directed to triazolopyridinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
    Type: Application
    Filed: November 9, 2012
    Publication date: November 20, 2014
    Applicant: Merck Sharpe & Dohme Corp.
    Inventors: James C. Barrow, Christopher D. Cox, Mark B. Nolt, William D. Shipe